| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | 0.12 | 3e-05 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.16 | 4e-05 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.42 | 4e-05 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.19 | 4e-05 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.15 | 5e-05 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | 0.13 | 5e-05 |
| mRNA | LAQ824 | GDSC1000 | pan-cancer | AAC | 0.14 | 6e-05 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.15 | 6e-05 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | 0.15 | 6e-05 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.15 | 6e-05 |